Scarica l'app Stockscreener
22.77
2.86%
-0.68
Dopo l'orario di chiusura:
22.77
Precedente Chiudi:
$23.45
Aprire:
$23.46
Volume 24 ore:
351.04K
Relative Volume:
0.55
Capitalizzazione di mercato:
$1.02B
Reddito:
$681.75M
Utile/perdita netta:
$70.47M
Rapporto P/E:
15.70
EPS:
1.45
Flusso di cassa netto:
$173.19M
1 W Prestazione:
-1.21%
1M Prestazione:
-14.07%
6M Prestazione:
-6.91%
1 anno Prestazione:
+36.98%
Intervallo 1D:
$22.70
$23.51
Intervallo di 1 settimana:
$22.02
$23.51
Portata 52W:
$16.00
$27.98
Pacira Biosciences Inc Stock (PCRX) Company Profile
Nome
Pacira Biosciences Inc
Settore
Telefono
650-242-8052
Indirizzo
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Confronta PCRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCRX
Pacira Biosciences Inc
|
22.77 | 1.02B | 681.75M | 70.47M | 173.19M | 1.45 |
|
ZTS
Zoetis Inc
|
143.24 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.89 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.185 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.62 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-25 | Aggiornamento | Truist | Hold → Buy |
| 2025-01-30 | Aggiornamento | Truist | Sell → Hold |
| 2024-08-13 | Downgrade | Truist | Buy → Sell |
| 2024-08-12 | Downgrade | JP Morgan | Overweight → Underweight |
| 2024-08-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-08-12 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-07-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-03-07 | Ripresa | JP Morgan | Overweight |
| 2023-12-20 | Iniziato | Raymond James | Outperform |
| 2023-08-03 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-01-31 | Ripresa | Wedbush | Outperform |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-01-03 | Ripresa | JP Morgan | Overweight |
| 2021-07-26 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-04-21 | Ripresa | JP Morgan | Neutral |
| 2021-04-09 | Iniziato | Berenberg | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-02-11 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2021-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-09-21 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-06 | Reiterato | Needham | Buy |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-04-07 | Iniziato | Northland Capital | Outperform |
| 2020-03-20 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-02-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-24 | Iniziato | SunTrust | Buy |
| 2020-01-23 | Iniziato | SunTrust | Buy |
| 2019-11-06 | Iniziato | BTIG Research | Buy |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-05-06 | Aggiornamento | Mizuho | Underperform → Neutral |
| 2019-05-02 | Aggiornamento | Stifel | Sell → Hold |
| 2019-02-01 | Downgrade | Mizuho | Neutral → Underperform |
| 2018-08-06 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-21 | Reiterato | Mizuho | Neutral |
| 2018-02-16 | Downgrade | Needham | Buy → Hold |
| 2018-01-19 | Iniziato | Seaport Global Securities | Buy |
| 2018-01-04 | Reiterato | Canaccord Genuity | Buy |
| 2018-01-03 | Iniziato | Leerink Partners | Mkt Perform |
Mostra tutto
Pacira Biosciences Inc Borsa (PCRX) Ultime notizie
Chart based analysis of Pacira BioSciences Inc. trends2025 Top Decliners & Daily Growth Stock Investment Tips - newser.com
How to manage a losing position in Pacira BioSciences Inc.Earnings Recap Summary & Fast Entry High Yield Tips - newser.com
How Pacira BioSciences Inc. (82P) stock behaves under inflation pressureJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Can a trend reversal in Pacira BioSciences Inc. lead to recoveryTreasury Yields & Long-Term Growth Plans - newser.com
Using Ichimoku Cloud for Pacira BioSciences Inc. technicalsWeekly Profit Summary & Risk Managed Investment Entry Signals - newser.com
What momentum shifts mean for Pacira BioSciences Inc.2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Will Pacira BioSciences Inc. (82P) stock split increase liquidity2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Reach Out - ACCESS Newswire
Pacira BioSciences (NASDAQ:PCRX) Given "Sell (D)" Rating at Weiss Ratings - MarketBeat
How to interpret RSI for Pacira BioSciences Inc. stock2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
Detecting support and resistance levels for Pacira BioSciences Inc.July 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com
Pacira BioSciences Inc. stock trend outlook and recovery path2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com
What moving averages say about Pacira BioSciences Inc.Weekly Trend Report & Weekly Top Gainers Alerts - newser.com
Pacira BioSciences Inc. stock volume spike explained2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Custom watchlist performance reports with Pacira BioSciences Inc.2025 Stock Rankings & Growth Oriented Trading Recommendations - newser.com
Pacira BioSciences Becomes Oversold (PCRX) - Nasdaq
A Look at Pacira BioSciences (PCRX) Valuation Following Recent Strategic Partnership News - Sahm
Pacira BioSciences, Inc. $PCRX Shares Bought by Gagnon Securities LLC - MarketBeat
Gagnon Advisors LLC Has $5.10 Million Position in Pacira BioSciences, Inc. $PCRX - MarketBeat
Robeco Institutional Asset Management B.V. Has $1.29 Million Holdings in Pacira BioSciences, Inc. $PCRX - MarketBeat
Pacira Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Possible Bearish Signals With Pacira BioSciences Insiders Disposing Stock - simplywall.st
Pacira BioSciences, Inc. (PCRX) Stock Analysis: Unlocking a 21.49% Upside Potential for Investors - DirectorsTalk Interviews
Raymond James Maintains Pacira BioSciences(PCRX.US) With Hold Rating - 富途牛牛
Applying Elliott Wave Theory to Pacira BioSciences Inc.Fed Meeting & Smart Money Movement Alerts - newser.com
Long term hold vs stop loss in Pacira BioSciences Inc.July 2025 Macro Moves & Stepwise Trade Signal Implementation - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Connect - ACCESS Newswire
Will Pacira BioSciences Inc. stock gain from government policiesWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com
Using Bollinger Bands to evaluate Pacira BioSciences Inc.Chart Signals & Entry Point Confirmation Alerts - newser.com
Can Pacira BioSciences Inc. (82P) stock hold up in economic slowdownPrice Action & Daily Stock Momentum Reports - newser.com
Greenwood Capital Associates LLC Takes $314,000 Position in Pacira BioSciences, Inc. $PCRX - MarketBeat
Why Institutions Believe Medinova Diagnostic Services Limited Is Undervalued TodayDividend Aristocrats List & Free Unlock Portfolio Growth - earlytimes.in
What drives Pacira BioSciences Inc stock priceLarge Cap Stability Picks & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Pacira Biosciences (PCRX) Grants Inducement Awards to New Employ - GuruFocus
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Pacira BioSciences reports inducement grants - MarketScreener
50,600 Shares: Pacira Grants Inducement Awards to 15 New Employees; $24.58 Exercise Price - Stock Titan
Why Pacira BioSciences Inc. (82P) stock could outperform next yearPortfolio Performance Summary & Growth Focused Investment Plans - newser.com
Pacira Biosciences Inc Azioni (PCRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.02%
5.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):